CEO
SOCIUM Inc.
The startup utilizes a systems biology approach to analyze omics data for drug repositioning, enabling the identification of new therapeutic uses for existing pharmaceuticals. This method addresses the challenge of lengthy and costly drug discovery processes by leveraging already commercialized drugs to find unexpected treatments for various diseases.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$4.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup utilizes a systems biology approach to analyze omics data for drug repositioning, enabling the identification of new therapeutic uses for existing pharmaceuticals. This method addresses the challenge of lengthy and costly drug discovery processes by leveraging already commercialized drugs to find unexpected treatments for various diseases.